drugset / Trial / NCT01365117

Pharmacokinetic Study in Healthy Volunteers

NCT01365117

Phase 1 Completed 50 enrolled Mannkind Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

Phase 1 clinical trial to evaluate insulin exposure using different formulations of Technosphere Insulin Inhalation Powder using the Gen2 inhaler in healthy normal volunteers.

Timeline

Start
2011-01
Primary completion
2011-02
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 20 iu Inhaled
Subject Insulin Protein / enzyme biologic 30 iu Inhaled
Subject Insulin Protein / enzyme biologic 40 iu Inhaled

Indications

No indication recorded.